HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Lu Selected Research

Sulfides (Thioethers)

8/2019Design, synthesis and biological evaluation of the thioether-containing lenalidomide analogs with anti-proliferative activities.
5/2018The combined therapeutic effects of 131iodine-labeled multifunctional copper sulfide-loaded microspheres in treating breast cancer.
1/2018131I-Labeled Copper Sulfide-Loaded Microspheres to Treat Hepatic Tumors via Hepatic Artery Embolization.
7/2015Direct Dry-Grinding Synthesis of Monodisperse Lipophilic CuS Nanoparticles.
6/2014Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles.
10/2010Copper sulfide nanoparticles for photothermal ablation of tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Lu Research Topics

Disease

274Neoplasms (Cancer)
06/2022 - 06/2002
73Breast Neoplasms (Breast Cancer)
03/2022 - 11/2007
57Infections
02/2022 - 08/2003
40Neoplasm Metastasis (Metastasis)
05/2022 - 06/2005
37Inflammation (Inflammations)
09/2022 - 01/2006
30Type 2 Diabetes Mellitus (MODY)
07/2022 - 04/2006
25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 03/2010
24Hepatocellular Carcinoma (Hepatoma)
07/2022 - 06/2002
23Lung Neoplasms (Lung Cancer)
11/2021 - 05/2004
21Chronic Hepatitis B
07/2022 - 09/2012
20Fibrosis (Cirrhosis)
07/2022 - 10/2003
19Body Weight (Weight, Body)
06/2022 - 09/2005
17Prostatic Neoplasms (Prostate Cancer)
06/2022 - 04/2005
17Carcinogenesis
06/2022 - 10/2003
15Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 09/2012
15Carcinoma (Carcinomatosis)
01/2022 - 03/2005
14Tuberculosis (Tuberculoses)
05/2022 - 10/2004
13Cardiovascular Diseases (Cardiovascular Disease)
09/2021 - 01/2007
11Ischemia
02/2022 - 11/2007
11Alzheimer Disease (Alzheimer's Disease)
01/2022 - 09/2014
11Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2006
11Melanoma (Melanoma, Malignant)
01/2022 - 02/2009
11Pain (Aches)
01/2022 - 01/2006
11Wounds and Injuries (Trauma)
01/2022 - 12/2008
11Osteoarthritis
07/2021 - 02/2012
10Stroke (Strokes)
01/2022 - 12/2010
10Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 06/2018
10Epilepsy (Aura)
01/2021 - 10/2007
10Schizophrenia (Dementia Praecox)
01/2021 - 12/2010
10Glioma (Gliomas)
01/2019 - 06/2005
10Gallbladder Neoplasms (Gallbladder Cancer)
10/2017 - 07/2014
10Burns
10/2016 - 04/2002
9Insulin Resistance
09/2022 - 03/2009
9Obesity
06/2022 - 12/2006
9Ovarian Neoplasms (Ovarian Cancer)
03/2022 - 08/2009
9Hypoxia (Hypoxemia)
02/2022 - 07/2006
9Shock
01/2022 - 10/2002
9Acquired Immunodeficiency Syndrome (AIDS)
01/2022 - 10/2003
9Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 01/2019
9Hepatitis B
11/2020 - 01/2012
8Hemorrhage
01/2022 - 12/2013
8Leukemia
01/2022 - 06/2005
8Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 12/2014
8Liver Neoplasms (Liver Cancer)
01/2021 - 06/2005

Drug/Important Bio-Agent (IBA)

69Proteins (Proteins, Gene)FDA Link
12/2022 - 04/2005
54Pharmaceutical PreparationsIBA
04/2022 - 06/2002
49Glucose (Dextrose)FDA LinkGeneric
09/2022 - 09/2005
40Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2004
33Biological ProductsIBA
01/2022 - 05/2004
23Messenger RNA (mRNA)IBA
12/2021 - 11/2003
21Long Noncoding RNAIBA
05/2022 - 01/2015
17Insulin (Novolin)FDA Link
09/2022 - 06/2008
17ProdrugsIBA
02/2022 - 04/2013
17CytokinesIBA
01/2022 - 08/2008
17Estrogen ReceptorsIBA
01/2021 - 10/2008
15RNA (Ribonucleic Acid)IBA
05/2022 - 04/2017
15EnzymesIBA
01/2022 - 08/2008
15DNA (Deoxyribonucleic Acid)IBA
11/2021 - 10/2003
14LigandsIBA
01/2022 - 08/2005
13MicroRNAs (MicroRNA)IBA
06/2022 - 01/2015
13Hepatitis B e AntigensIBA
11/2021 - 01/2016
12Blood Glucose (Blood Sugar)IBA
09/2022 - 06/2008
12VaccinesIBA
01/2022 - 01/2003
12GoldIBA
10/2017 - 06/2008
12Estrogens (Estrogen)FDA Link
06/2016 - 01/2009
11Therapeutic UsesIBA
03/2022 - 10/2007
11AlbuminsIBA
01/2022 - 10/2006
11Indicators and Reagents (Reagents)IBA
01/2022 - 01/2013
11Peptides (Polypeptides)IBA
01/2022 - 06/2003
11Phosphotransferases (Kinase)IBA
10/2020 - 08/2008
10LipidsIBA
09/2022 - 02/2015
10Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2021 - 05/2003
10AntigensIBA
12/2020 - 09/2006
10InterferonsIBA
11/2020 - 08/2012
10ORALIT (ORS)IBA
01/2020 - 11/2007
9MicellesIBA
04/2020 - 12/2012
9Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 - 04/2008
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2022 - 08/2005
8AcidsIBA
02/2022 - 07/2010
8Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 04/2011
8AntioxidantsIBA
01/2022 - 01/2008
8Oxygen (Dioxygen)IBA
01/2022 - 04/2002
8AntibodiesIBA
04/2021 - 06/2003
8Paclitaxel (Taxol)FDA LinkGeneric
05/2020 - 08/2009
8CamptothecinIBA
04/2020 - 05/2013
8Hormones (Hormone)IBA
04/2020 - 04/2011
8Irinotecan (Camptosar)FDA LinkGeneric
01/2020 - 02/2007
82- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2019 - 06/2008
8Antineoplastic Agents (Antineoplastics)IBA
10/2019 - 06/2002
8CopperIBA
05/2018 - 11/2009
7GemcitabineFDA Link
07/2022 - 05/2013

Therapy/Procedure

124Therapeutics
07/2022 - 05/2004
31Drug Therapy (Chemotherapy)
07/2022 - 12/2004
19Radiotherapy
01/2021 - 08/2006
15Immunotherapy
11/2021 - 07/2011
14Lasers (Laser)
03/2022 - 04/2007
12Aftercare (After-Treatment)
11/2022 - 01/2013
9Electroacupuncture
06/2022 - 11/2018
8Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 11/2014
8Glycemic Control
09/2021 - 11/2004